Fig. 1From: A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD studyDONIPAD study timeline. DONIPAD DONepezil In Posterior cortical atrophy due to underlying Alzheimer’s DiseaseBack to article page